Synthetic Biologics appoints Maureen Early as vice president of commercial

Microbiome-focused company Synthetic Biologics has appointed Maureen Early to the newly-created position of vice president, commercial.

She will lead all commercial and marketing operations for the company’s product portfolio. Ms Early was president and co-founder of privately-owned independent medical strategic and communications company.

Jeff Riley, president and chief executive, said: "Maureen has over 20 years of global and domestic strategic marketing executive experience in the pharmaceutical industry working on products from pre-launch through post-launch. During her career she has successfully launched several products, created effective anti-infective marketing programs and developed solutions to optimize brand lifecycles. Her strong track record should be of enormous benefit to Synthetic Biologics as we enter our next phase of development and growth. I look forward to working with Maureen and her team as we move our microbiome-focused product portfolio through the clinic and plan for commercial entry."